Femseven (estradiol transdermal) / Theramex, EMD Serono - LARVOL DELTA

The Case for, and Challenges to, using Transdermal Estradiol for Androgen Deprivation Therapy (AUA 2025) - "The RCT evidence used Femseven and Progynova TS 100 mcg patches initially 4 patches changed twice weekly, then 3 patches twice weekly when testosterone was<1.7 nmol/L. Despite randomized phase III data endorsing tE2 for ADT, PCa patients encounter barriers to accessing tE2. Our data indicate the need for further research on tE2 products to treat PCa. There is currently a strong case for a license extension of products initially developed to treat menopausal symptoms in women."

Clinical • Genito-urinary Cancer • Oncology • Prostate Cancer • Solid Tumor